John Smither

John Smither

Financieel Directeur/CFO bij MBX BIOSCIENCES, INC.

Vermogen: 2 M $ op 31-08-2026

73 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

John William Smither is currently an Independent Director at Genelux Corp.
since 2023, an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV since 2023, a Director at eFFECTOR Therapeutics Operations, Inc. since 2018, an Independent Director at Attovia Therapeutics, Inc. starting in 2026, and Chief Financial Officer at MBX Biosciences, Inc. starting in 2026.
Memberships include The American Institute of Certified Public Accountants, Financial Executives International, and California Society of Certified Public Accountants.
Former roles include Independent Director at Achaogen, Inc. from 2013 to 2020, Independent Director at Principia Biopharma, Inc. in 2019, Director at Dompe Biotec SpA, Independent Director at eFFECTOR Therapeutics, Inc. from 2018 to 2023, Independent Director at Applied Molecular Transport, Inc. from 2022 to 2023, Vice President-Finance & Administration at Amgen, Inc. from 2001 to 2004, Chief Financial Officer at Kythera Biopharmaceuticals LLC from 2007 to 2015, Audit Partner at Ernst & Young LLP (Missouri), Chief Financial Officer at Amgen Europe BV from 2001 to 2004, Chief Financial Officer at Kite Pharma, Inc. from 2017 to 2018, Chief Financial Officer at Unity Biotechnology, Inc. from 2016 to 2017, Chief Financial Officer at Sienna Biopharmaceuticals, Inc. from 2016 to 2017 and again from 2018 to 2019, Chief Financial Officer at Arcutis Biotherapeutics, Inc. from 2019 to 2021 and from 2023 to 2024.
Education includes undergraduate studies at California State University-Los Angeles.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
03-08-2026 28.000 ( 0,06% ) 2 M $ 31-08-2026
01-07-2026 91.403 ( 0,2% ) 239 019 $ 31-08-2026
04-09-2026 8.760 ( 0,01% ) 221 978 $ 31-08-2026

Actieve functies van John Smither

BedrijvenFunctieBegin
FRAZIER LIFESCIENCES ACQUISITION CORPORATION Directeur/Bestuurslid 01-01-2023
GENELUX CORPORATION Directeur/Bestuurslid 11-09-2023
MBX BIOSCIENCES, INC. Financieel Directeur/CFO 01-03-2026
ATTOVIA THERAPEUTICS, INC. Directeur/Bestuurslid 01-07-2026
Directeur/Bestuurslid 23-03-2018
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Eerdere bekende functies van John Smither

BedrijvenFunctieEinde
ARCUTIS BIOTHERAPEUTICS, INC. Financieel Directeur/CFO 10-04-2024
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van John Smither in detail bekijken

Opleiding van John Smither

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

70

Eerstegraads connecties

22

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit22

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. John Smither